Genome sequencing can help the medical world make more specific diagnostics and Indonesia will get the benefit from developing the method, an Indonesian health ministry official has said.
“The genomic sequencing approach can be applied for the diagnostic stage in health. We can create specific diagnostic tools based on genomic data from the Indonesian population,” pharmacy and health device director general at the Ministry of Health, Rizka Andalusia, said in a health discussion here on Thursday.
The medical trend that will grow in the future will target personalized medication and this can be done through the genomic database, she said.
She highlighted the fact that Indonesia has a large human population with potentially diverse genomic data.
“Actually, genome sequencing in health in Indonesia is still in the early stage. However, we have a very high potential for genome sequencing in health,” she said.
Throughout this time, diagnosis tools, vaccines, and medicines have been developed based on studies of Caucasian populations. This, she said, is despite the fact that Indonesians or Asians genetically have different genomic data compared to Caucasians.
Thus, scientific advancements in genome sequencing can be utilized to develop diagnostic tools, vaccines, and medicines that suit the Indonesian population for more accurate prevention and medication.
“To diagnose, let’s say a genetic disorder or cancer, we need accurate handling and diagnostics,” Andalusia said.
“Genomic profile or genomic approach became their own challenges for us in the development of diagnostic tools, vaccines, and medicines,” she added.
Andalusia noted that the implementation of genome sequencing in health in Indonesia has risen ever since the COVID-19 pandemic. This method has been utilized by the government for COVID-19 mitigation in Indonesia.
The ministry has also unveiled the Biomedical & Genome Science Initiative (BGSi), which is a program for expediting research by relying on genome sequencing technology.
Given how important technological development is for the utilization of genome sequencing in health, Andalusia urged various parties, such as academicians, researchers, and startups, to create synergy in the process.
Source: Antara News